- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02710942
Testing myWHI: Online Self-guided Programs for Migraine
October 15, 2018 updated by: Anna Huguet, IWK Health Centre
Testing the Feasibility of Two Self-guided Web-based Interventions for Adolescents and Young Adults With Migraine: A Pilot Randomized Controlled Trial
The goal for this pilot study is to assess the acceptability of two online self-guided programs for migraines.
The programs are part of the investigators' collection of "my Wireless Headache Interventions" (myWHI).
The Specialized Program for Headache Reduction (SPHERE) is a program that teaches cognitive and behavioural skills/techniques to help manage headaches.
The PeRsonalized Intervention for Self-Management of Migraine (PRISM) helps users to discover their headache triggers and provides recommendations for managing them.
This pilot will also assess the feasibility of the study protocol to inform a full scale randomized controlled trial (RCT).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3K 6R8
- IWK Health Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 35 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- aged 14-35 years
- fluent in the English language (i.e., speaking, reading and writing);
- suffer from headaches for a minimum of one year
- stable pattern of headache symptoms (e.g., headache frequency, severity, location of pain, symptoms associated with headache) for the past 6 months
- suffer from migraine headaches as indicated with a score of 2 and above on the ID Migraine
- use the Smartphone for activities other than texting and calling (e.g., email, Facebook)
- have daily Internet access from their Smartphone
- minimum of four headache days during 4 weeks of using an electronic headache diary
Exclusion Criteria:
- health care professional has not ruled out any underlying medical condition related to their headaches (e.g., head trauma, meningitis)
- are pregnant, planning to get pregnant (in the next 4 to 6 months), or breastfeeding
- have an impairment which compromises their ability to give informed consent
- having been diagnosed with psychosis and/or schizophrenia
- they complete less than 50% of daily entries (i.e., less than 14 daily entries) in an electronic headache dairy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: SPHERE intervention
It is a comprehensive self-guided Internet-based cognitive-behavioral therapy (CBT) that includes three components: (1) the myWHI diary.
(2) 30 multi-media learning topics that the user is encouraged to go through in a sequential way.
The topics contain education information and teach strategies to cope better with their headaches.
|
|
|
EXPERIMENTAL: PRISM intervention
It is a targeted self-guided Internet-based CBT intervention.
PRISM was built upon the myWHI diary, an electronic headache diary.
PRISM helps users discover their headache triggers by analyzing the inputted diary data using association rule mining.
Once one or multiple headache triggers are identified the application uses an algorithm to provide the user with a few personalized recommendations to help them to cope with these triggers.
The algorithm is based on the opinion of clinical experts (e.g., medical health professionals, psychologists).
The user chooses recommendations to follow and sets goals in the application to follow them.
To support the process, the application checks in with users about their goals and tracks goal completion.
|
|
|
NO_INTERVENTION: Usual care
Participants can continue doing what they usually do to deal with their migraines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average number of individuals who complete the online screening per month
Time Frame: After reaching our desired sample size for randomization
|
This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size.
However, our maximum time frame is 1 year.
|
After reaching our desired sample size for randomization
|
|
Proportion of recruited participants who are eligible for study entry
Time Frame: After reaching our desired sample size for randomization
|
This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size.
However, our maximum time frame is 1 year.
|
After reaching our desired sample size for randomization
|
|
Proportion of eligible participants who consent
Time Frame: After reaching our desired sample size for randomization
|
This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size.
However, our maximum time frame is 1 year.
|
After reaching our desired sample size for randomization
|
|
Proportion of consented participants who are randomized
Time Frame: After reaching our desired sample size for randomization
|
This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size.
However, our maximum time frame is 1 year.
|
After reaching our desired sample size for randomization
|
|
Proportion of randomized participants who drop out
Time Frame: At 4-month post-randomization
|
At 4-month post-randomization
|
|
|
Level of usage of the Internet-based interventions (i.e., PRISM and SPHERE). Intervention usage will be tracked automatically
Time Frame: At 4-month post-randomization
|
At 4-month post-randomization
|
|
|
Proportion of consented participants who complete the baseline assessment
Time Frame: After reaching our desired sample size for randomization
|
This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size.
However, our maximum time frame is 1 year.
|
After reaching our desired sample size for randomization
|
|
Proportion of randomized participants who complete the 4-month post-randomization assessment
Time Frame: At 4-month post-randomization
|
At 4-month post-randomization
|
|
|
Acceptability of the Internet-based interventions (i.e., PRISM and SPHERE) using the 8-item Client Satisfaction Questionnaire (CSQ-8)
Time Frame: At 4-mont post-randomization
|
At 4-mont post-randomization
|
|
|
Acceptability of the Internet-based interventions (i.e., PRISM and SPHERE) using the single-item Patients' Global Impression of Change Scale (PGIC)
Time Frame: At 4-mont post-randomization
|
At 4-mont post-randomization
|
|
|
Acceptability of the Internet-based interventions (i.e., PRISM and SPHERE) using the satisfaction interviews
Time Frame: At 4-mont post-randomization
|
At 4-mont post-randomization
|
|
|
Proportion of participants in the control group who show clinically significant improvement (50% or greater reduction) from baseline in number of headache days in the last 4 weeks
Time Frame: At 4-mont post-randomization
|
At 4-mont post-randomization
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2016
Primary Completion (ACTUAL)
July 1, 2016
Study Completion (ACTUAL)
December 1, 2016
Study Registration Dates
First Submitted
November 12, 2015
First Submitted That Met QC Criteria
March 11, 2016
First Posted (ESTIMATE)
March 17, 2016
Study Record Updates
Last Update Posted (ACTUAL)
October 16, 2018
Last Update Submitted That Met QC Criteria
October 15, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSO-EST-2014-9575
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Migraine Headache
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingMigraine | Migraine Headache | Migraine Without Aura | Migraine with Aura | Chronic Migraine, Headache | Episodic Migraine | Chronic Migraine Headache | Headache (Migraine) | Episodic Migraine HeadacheSpain
-
University Medical Centre LjubljanaActive, not recruitingMigraine | Migraine Headache | Migraine Headache, With or Without Aura | Migraine in AdultsSlovenia
-
Ain Shams UniversityRecruitingMigraine | Migraine Headache | Migraine, Acute | Migraine Headache, With or Without Aura | Migraine DiseaseEgypt
-
The Cleveland ClinicWithdrawnMigraine | Migraine Disorders | Headache Disorders, Primary | Migraine Headache | Migraine Without Aura | Migraine With Aura | Headache, MigraineUnited States
-
Ariston Pharmaceuticals, Inc.UnknownMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraFinland, Netherlands, United Kingdom
-
Johns Hopkins UniversityMedtronicRecruitingMigraine | Chronic Migraine Headache | Refractory MigraineUnited States
-
Fundación de Investigación Biomédica - Hospital...Hospital Universitario La Fe; Hospital Vall d'Hebron; Hospital Universitario... and other collaboratorsRecruitingMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraSpain
-
Danish Headache CenterCompletedHeadache, Migraine | AuraDenmark
-
TheranicaActive, not recruitingMigraine | Chronic Migraine HeadacheUnited States
-
Benfida, a department of Handi-MoveArtialisRecruitingMigraine | Migraine Headache | Migraine in AdultsBelgium
Clinical Trials on SPHERE
-
Vitaflo International, LtdCompletedAlkaptonuria | Tyrosinemias | Tyrosinemia, Type I | Tyrosinemia, Type II | Tyrosinemia, Type IIIUnited Kingdom
-
IWK Health CentreCanadian Institutes of Health Research (CIHR); Nova Scotia Health Research...Unknown
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Vitaflo International, LtdCompleted
-
Oslo University HospitalMedacta International SACompleted
-
Northwestern UniversityCompletedOsteoarthritis of KneeUnited States
-
Medacta International SAActive, not recruitingArthritis | Rheumatoid Arthritis | Avascular Necrosis | Traumatic Arthritis | Poly-arthritisBelgium, United Kingdom
-
University of Alabama at BirminghamAlcon ResearchCompleted
-
Kathryn RichdaleCompleted